Analyses from a breast cancer patient and cell line databases also demonstrated that OVOL1 expression was inversely correlated with the TGF-β response signature (TBRS)54 or the levels of TGF-β/SMAD target genes (Supplementary Fig. 5c–e). This evidence concerns the gene OVOL1 and breast carcinoma.